Similar articles

• Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts.

  Wendel U, Wentrup H, Rüdiger HW. Wendel U, et al. Pediatr Res. 1975 Sep;9(9):709-17. doi: 10.1203/00006450-197509000-00005. Pediatr Res. 1975. PMID: 1202420
• The enzyme defect in maple syrup urine disease (branched chain ketoaciduria).

  Seegmiller JE, Westall RG. Seegmiller JE, et al. J Ment Defic Res. 1967 Dec;11(4):288-94. doi: 10.1111/j.1365-2788.1967.tb00233.x. J Ment Defic Res. 1967. PMID: 5582930 No abstract available.
• Heterogeneity in maple syrup urine disease: aspects of cofactor requirement and complementation in cultured fibroblasts.

  Singh S, Willers I, Goedde HW. Singh S, et al. Clin Genet. 1977 Apr;11(4):277-84. doi: 10.1111/j.1399-0004.1977.tb01313.x. Clin Genet. 1977. PMID: 192504
• [Maple syrup urine disease: molecular pathology of the branched chain alpha-keto acid dehydrogenase complex].

  Nobukuni Y, Mitsubuchi H, Indo Y, Endo F, Matsuda I. Nobukuni Y, et al. Seikagaku. 1992 Feb;64(2):67-82. Seikagaku. 1992. PMID: 1593184 Review. Japanese. No abstract available.
• [Gene analysis of maple syrup urine disease (MSUD)].

  Mitsubuchi H, Nobukuni Y, Hayashida Y, Ohta K, Indo Y, Akaboshi I, Endo F, Matsuda I. Mitsubuchi H, et al. Rinsho Byori. 1993 May;41(5):484-91. Rinsho Byori. 1993. PMID: 8350511 Review. Japanese.